Grammy-winning Americana crooner Jason Isbell is one of several new litigants in a new federal lawsuit against the AI music ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Scott Jenson, a veteran UX ...

OpenAI Structured Outputs enforces developer-defined JSON schemas, making AI responses structurally reliable while still requiring validation for factual accuracy, refusals, incomplete outputs, and ...

On Tuesday, Meta launched “Muse Image,” a new AI image-generation feature that allows users to create original images, edit existing photos, and even generate custom ads directly within its apps. But ...

Mindgard used a simple “restore this image” prompt (with no image attached) to see how easily ChatGPT could be steered into unsafe territory. An adversarial testing researcher named Jim Nightingale ...

There has been a sharp rise in so-called "nudification" technology. These AI-powered tools can generate realistic fake images and videos that depict people as undressed, often without their knowledge ...

NASHVILLE, Tenn. (WSMV) - A Nashville man was arrested this week for posting numerous sexual images depicting children online over the course of several months. An arrest affidavit from the Metro ...

Wikipedia has banned contributors from using artificial intelligence tools to create content for its platform through a recent policy update. The recently announced new guidelines reflect increasing ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...